Renfeng Shan

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience

Laihui Luo, Yongqiang Xiao, Guoqing Zhu et al. · Frontiers in Oncology · 2022 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma

Yongzhu He, Laihui Luo, Renfeng Shan et al. · Journal of the National Comprehensive Cancer Network · 2023 · 36 citations · Full text

Medicine, Oncology, Surgery +14

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?

Laihui Luo, Yongzhu He, Guoqing Zhu et al. · Journal of Hepatocellular Carcinoma · 2022 · 31 citations · Full text

Medicine, Surgery, Hepatology +11

The Prognostic Value of the MiR-200 Family in Colorectal Cancer: A Meta-analysis with 1882 Patients

Chengpeng Yu, Haiting Wan, Renfeng Shan et al. · Journal of Cancer · 2019 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17

Combined identification of three <scp>lncRNAs</scp> in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus‐related hepatocellular carcinoma

Peng Fu, Binbin Gong, Huiming Li et al. · International Journal of Cancer · 2022 · 18 citations

Medicine, Molecular Biology, Oncology +17